(WELL) Welltower - Overview

Sector: Real Estate | Industry: REIT - Healthcare Facilities | Exchange: NYSE (USA) | Market Cap: 155.400m USD | Total Return: 44.1% in 12m

Senior Housing, Assisted Living, Memory Care, Wellness Centers

Total Rating 52

Safety 46

Buy Signal -0.85

REIT - Healthcare Facilities
Industry Rotation: +13.6

Market Cap: 155B
Avg Turnover: 608M

Risk 3d forecast

Volatility22.0%

VaR 5^th Pctl3.90%

VaR vs Median7.83%

Reward TTM

Sharpe Ratio1.81

Rel. Str. IBD68.3

Rel. Str. Peer Group75

Character TTM

Beta0.032

Beta Downside-0.184

Hurst Exponent0.541

Drawdowns 3y

Max DD12.99%

CAGR/Max DD3.41

CAGR/Mean DD15.46

EPS (Earnings per Share)

EPS CAGR: 30.77%
EPS Trend: 81.8%

Last SUE: 0.33
Qual. Beats: 0

Revenue

Rev. CAGR: 25.54%
Rev. Trend: 97.5%

Last SUE: 1.37
Qual. Beats: 2

Warnings

P/E ratio 106.3

High Debt/EBITDA (5.8) with thin interest coverage (0.5)

Interest Coverage Ratio 0.5 is critical

Altman Z'' -0.30 < 1.0 - financial distress zone

Tailwinds

No distinct edge detected

Description: WELL Welltower

Welltower Inc. (NYSE: WELL) is an S&P 500 real estate investment trust (REIT) specializing in senior housing and wellness infrastructure across the United States, United Kingdom, and Canada. The company manages a portfolio of over 2,000 properties, utilizing a proprietary data science platform and the Welltower Business System to optimize capital allocation and operational performance.

Operating within the Health Care REIT sector, Welltower utilizes the Senior Housing Operating Portfolio (SHOP) model, which allows the company to participate directly in the propertys net operating income rather than relying solely on fixed rent payments. This business model leverages the silver economy, a sector driven by the demographic shift of aging populations in developed markets requiring specialized rental housing and hospitality services.

Investors can further evaluate the companys long-term compounding potential by reviewing the latest valuation metrics on ValueRay.

Incorporated in 1970, Welltower functions as an operating company within a real estate framework, focusing on high-barrier-to-entry micro-markets. The firm prioritizes strategic partnerships to drive per-share growth and portfolio scaling within the intersection of healthcare and residential real estate.

Headlines to Watch Out For

Aging population demographics drive occupancy growth in senior housing operating portfolios
Rising labor costs and healthcare staffing shortages pressure property level operating margins
Data science driven capital allocation optimizes yields across high barrier to entry markets
Interest rate fluctuations impact financing costs and valuation of long term real estate assets
Strategic partnerships with health systems enhance revenue per occupied room in wellness communities

Piotroski VR‑10 (Strict) 3.5

Net Income: 1.41b TTM > 0 and > 6% of Revenue
FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.71 > 1.0
NWC/Revenue: 43.73% < 20% (prev 65.28%; Δ -21.55% < -1%)
CFO/TA 0.04 > 3% & CFO 2.95b > Net Income 1.41b
Net Debt (15.28b) to EBITDA (2.64b): 5.79 < 3
Current Ratio: 3.20 > 1.5 & < 3
Outstanding Shares: last quarter (726.3m) vs 12m ago 11.08% < -2%
Gross Margin: 38.87% > 18% (prev 0.38%; Δ 3.85k% > 0.5%)
Asset Turnover: 19.22% > 50% (prev 15.78%; Δ 3.44% > 0%)
Interest Coverage Ratio: 0.52 > 6 (EBITDA TTM 2.64b / Interest Expense TTM 699.7m)

Altman Z'' -0.30

A: 0.08 (Total Current Assets 7.37b - Total Current Liabilities 2.31b) / Total Assets 67.22b
B: -0.13 (Retained Earnings -8.96b / Total Assets 67.22b)
C: 0.01 (EBIT TTM 366.2m / Avg Total Assets 60.26b)
D: -0.39 (Book Value of Equity -8.59b / Total Liabilities 22.29b)
Altman-Z'' Score: -0.30 = B

Beneish M -3.72

DSRI: 0.52 (Receivables 2.55b/3.58b, Revenue 11.58b/8.41b)
GMI: 0.98 (GM 38.87% / 38.23%)
AQI: 0.10 (AQ_t 0.09 / AQ_t-1 0.84)
SGI: 1.38 (Revenue 11.58b / 8.41b)
TATA: -0.02 (NI 1.41b - CFO 2.95b) / TA 67.22b)
Beneish M-Score: -3.72 (Cap -4..+1) = AAA

What is the price of WELL shares? As of May 18, 2026, the stock is trading at USD 213.74 with a total of 4,530,856 shares traded.
Over the past week, the price has changed by -0.07%, over one month by +1.88%, over three months by -0.12% and over the past year by +44.06%.

Is WELL a buy, sell or hold? Welltower has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy WELL.

StrongBuy: 10
Buy: 6
Hold: 4
Sell: 0
StrongSell: 0

What are the forecasts/targets for the WELL price?

Analysts Target Price	233	9%

Welltower (WELL) - Fundamental Data Overview as of 15 May 2026

P/E Trailing = 106.3478
P/E Forward = 72.9927
P/S = 13.2066
P/B = 3.4596
P/EG = 3.6218
Revenue TTM = 11.58b USD
EBIT TTM = 366.2m USD
EBITDA TTM = 2.64b USD
Long Term Debt = 17.93b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 19.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.28b USD (from netDebt column, last quarter)
Enterprise Value = 170.68b USD (155.40b + Debt 19.98b - CCE 4.70b)
Interest Coverage Ratio = 0.52 (Ebit TTM 366.2m / Interest Expense TTM 699.7m)
EV/FCF = 67.14x (Enterprise Value 170.68b / FCF TTM 2.54b)
FCF Yield = 1.49% (FCF TTM 2.54b / Enterprise Value 170.68b)
FCF Margin = 21.94% (FCF TTM 2.54b / Revenue TTM 11.58b)
Net Margin = 12.15% (Net Income TTM 1.41b / Revenue TTM 11.58b)
Gross Margin = 38.87% ((Revenue TTM 11.58b - Cost of Revenue TTM 7.08b) / Revenue TTM)
Gross Margin QoQ = 37.82% (prev 38.30%)
Tobins Q-Ratio = 2.54 (Enterprise Value 170.68b / Total Assets 67.22b)
Interest Expense / Debt = 0.96% (Interest Expense 192.7m / Debt 19.98b)
Taxrate = 1.52% (11.6m / 764.0m)
NOPAT = 360.6m (EBIT 366.2m * (1 - 1.52%))
Current Ratio = 3.20 (Total Current Assets 7.37b / Total Current Liabilities 2.31b)
Debt / Equity = 0.46 (Debt 19.98b / totalStockholderEquity, last quarter 43.79b)
Debt / EBITDA = 5.79 (Net Debt 15.28b / EBITDA 2.64b)
Debt / FCF = 6.01 (Net Debt 15.28b / FCF TTM 2.54b)
Total Stockholder Equity = 40.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.34% (Net Income 1.41b / Total Assets 67.22b)
RoE = 3.51% (Net Income TTM 1.41b / Total Stockholder Equity 40.15b)
RoCE = 0.63% (EBIT 366.2m / Capital Employed (Equity 40.15b + L.T.Debt 17.93b))
RoIC = 0.63% (NOPAT 360.6m / Invested Capital 57.63b)
WACC = 5.50% (E(155.40b)/V(175.38b) * Re(6.09%) + D(19.98b)/V(175.38b) * Rd(0.96%) * (1-Tc(0.02)))
Discount Rate = 6.09% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 100.00 | Cagr: 12.93%
[DCF] Terminal Value 88.44% ; FCFF base≈2.48b ; Y1≈3.06b ; Y5≈5.22b
[DCF] Fair Price = 193.1 (EV 151.57b - Net Debt 15.28b = Equity 136.29b / Shares 705.9m; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 81.83 | EPS CAGR: 30.77% | SUE: 0.33 | # QB: 0
Revenue Correlation: 97.51 | Revenue CAGR: 25.54% | SUE: 1.37 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.57 | Chg30d=-8.80% | Revisions=N/A | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.65 | Chg30d=-6.25% | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=2.97 | Chg30d=+20.24% | Revisions=N/A | GrowthEPS=+117.2% | GrowthRev=+29.4%
EPS next Year (2027-12-31): EPS=3.33 | Chg30d=+1.22% | Revisions=+20% | GrowthEPS=+12.1% | GrowthRev=+13.7%
[Analyst] Revisions Ratio: +20%